TA
APLS

Teachers Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Teachers Advisors’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.53M Buy
78,549
+5,826
+8% +$91.6K ﹤0.01% 2107
2018
Q4 		$959K Hold
72,723
– – ﹤0.01% 2209
2018
Q3 		$1.29M Buy
72,723
+3,716
+5% +$68.7K ﹤0.01% 2188
2018
Q2 		$1.52M Buy
69,007
+51,696
+299% +$1.19M ﹤0.01% 2114
2018
Q1 		$383K Buy
17,311
+4,876
+39% +$95.8K ﹤0.01% 2642
2017
Q4 		$270K Buy
+12,435
New +$183K ﹤0.01% 2845

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Teachers Advisors's APLS Position: Q1 2019 in Review

Teachers Advisors increased its Apellis Pharmaceuticals (APLS) stake by 8% in Q1 2019, buying an estimated $91.6K and bringing the position to 78,549 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2107.

Teachers Advisors first reported a position in APLS in Q4 2017 and has held it in 6 quarters since. 92 funds tracked by Wall St. Rank hold APLS as of Q1 2019.

  • Teachers Advisors held 78,549 shares of Apellis Pharmaceuticals worth $1.53M as of Q1 2019.
  • Teachers Advisors bought 5,826 Apellis Pharmaceuticals shares in Q1 2019, an estimated $91.6K.
  • Apellis Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2107 holding.
  • Teachers Advisors first reported a position in Apellis Pharmaceuticals in Q4 2017 and has held it in 6 quarters since.
  • 92 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.